Our Board of Trustees are a group of volunteers responsible for our strategy and for making sure we are best meeting the needs of people affected by blood cancer.
John became our Chair in September 2018 and has extensive experience of non-executive roles across the private, public and charity sectors. After studying physics at university, he spent over 30 years with accounting firms Arthur Andersen, where he became UK Managing Partner, and Deloitte, as Senior Partner for the London Practice. Since then he has had a number of non-executive positions, including: Non-Executive Director of ITV plc; Board member of Transport for London; Non-Executive Director of Gemalto NV and Constellium NV; and trustee of the Roundhouse Trust and the Design Museum.
Tim is a Chartered Accountant, with 30 years’ experience in the financial services and investments industry. Most recently he spent 13 years at Columbia Threadneedle Investments, initially as Chief Financial Officer, then Chief Operating Officer and finally as interim Chief Executive Officer. Tim is also Director of TR Property Investment Trust Plc and of Henderson Global Investors Limited.
Frances Balkwill is a Professor of Cancer Biology at Barts Cancer Institute, Queen Mary University of London, and Deputy Lead of the Centre for the Tumour Microenvironment. She is a fellow of the Academy of Medical Sciences and was awarded an OBE in 2008. In 2015 she was made a Doctor of Science honoris causa by the University of Bristol, and in 2017 was awarded the Cancer Research UK Inspiring Leadership in Research Engagement Prize.
After graduating with a degree in modern languages, Simon spent 5 years in Management Consulting before 14 years in television with MTV Networks Europe where he became CEO. Since 2007 Simon has been working with a range of early stage digital businesses as advisor and non-executive director. He is currently a director of two German businesses, Babbel and Spreadshirt. He is also Chairman of 8Fit, an online fitness company; Boilerjuice, a platform for buying domestic heating oil; Picfair, a photography platform, and Get Licensed, an occupational license business. He holds an MBA from Insead.
Steve has been a volunteer for Blood Cancer UK for 24 years, starting as a member of his local branch after going into remission from acute promyelocytic leukaemia (APL). He then became a Regional Chair and in November 2017 joined the Board. Steve has spent the last two decades working in technology for organisations such as EDS, HP and Fujitsu. He is Head of Hybrid Cloud at the Department for Work and Pensions. Steve still fundraises with his local branch and has cycled London to Paris, Ride London, along with coast to coast rides for Blood Cancer UK and is the Trustee representative for our Public Fundraising portfolio.
Dr Jane Stevens
Jane trained as a medical doctor and specialised in haematology oncology. As a consultant in the NHS, she became increasingly interested in the complexity and challenge of organisational delivery of healthcare. She undertook an MBA at Ashridge Hult and worked as a clinical divisional director in an NHS provider organisation. In 2017 she was appointed faculty at Ashridge Hult. She is a visiting lecturer at the London School of Hygiene and Tropical Medicine. In March 2020, Jane returned to part-time clinical work in the NHS and to co-ordinate and deliver wellbeing support to healthcare professionals in an acute NHS Trust affected by the COVID pandemic.
Aileen joined HS2 in August 2019 as Strategic Director of Stakeholder Engagement and Communications, replacing Tom Kelly, who has been instrumental in shaping the strategic narrative for HS2 over the past five years. Aileen is an award-winning communications director with a career spanning both the public and private sectors. She brings with her a wealth of experience, having held directorships at the Government’s innovation Agency, Innovate UK, and, more recently, as Executive Director of Communications at the Association of the British Pharmaceutical Industry. She has also led communications functions for Vodafone and Kellogg’s.
Julia joined the Board in 2017 having previously chaired the Grimsby fundraising committee for Blood Cancer UK. She has been a lay member of Council for the University of Hull since 2014, and is a trustee of Lincolnshire Cares, a charity which aims to reduce isolation and loneliness in older people in the local community. She spent the majority of her career at regional law firm Wilkin Chapman LLP where she was CEO and Partner. Her qualifications include a BSc from the University of St Andrews, MBA from the University of Hull and Fellow of the Chartered Institute of Marketing.
Gemma is Chief Executive and a trustee of Blood Cancer UK. She joined the charity as CEO in September 2017. Prior to this she worked at King’s College London and King’s Health Partners as Executive Director of Fundraising and Supporter Development.